The aim of this study was to define guidelines for intravenous contras
t administration in cranial CT, as currently there are no recent guide
lines based on a large series of patients. In 1900 consecutive patient
s (1480 adults and 420 children) pre- and post-contrast scan was analy
sed in order to assess the contribution of contrast enhancement to the
diagnosis. The findings were grouped according to whether abnormaliti
es were seen on the pre- and/or post-contrast scan, or whether no abno
rmalities were seen at all. Sensitivity, specificity, positive predict
ive value, negative predictive value and accuracy of a pre-contrast sc
an were used to determine validity. Intravenous contrast enhancement o
nly contributes to the diagnosis if a suspicious abnormality is seen o
n the unenhanced scan or int he appropriate clinical setting (33.6%).
In the remaining patients (65.6%) there is no diagnostic contribution,
except for a small number of abnormalities (0.8%). These are often an
atomical variants and have no therapeutic impact. The number of contra
st-enhanced cranial CT examinations can significantly be reduced by us
ing four general guidelines for contrast administration resulting in c
onsiderable cost savings without affecting the quality of service to t
he patient. These guidelines are defined by the clinical findings/pres
entation or by the findings on the unenhanced scan. The number of cont
rast-related complications will be reduced, which may have medicolegal
implications. These guidelines can be applied in any radiology depart
ment.